Literature DB >> 96180

Pre-B cells: bone marrow persistence in anti-mu-suppressed mice, conversion to B lymphocytes, and recovery after destruction by cyclophosphamide.

P D Burrows, J F Kearney, A R Lawton, M D Cooper.   

Abstract

Chronic treatment of mice from birth with anti-mu antibodies aborts development of B lymphocytes and plasma cells. In these studies we show that bone marrow from anti-mu-treated mice contains a population of cells with cytoplasmic IgM, but which lack detectable cell-surface IgM. These cells are analogous to pre-B cells, defined in ontogenetic studies as the immediate precursors of B lymphocytes. Pre-B cells from bone marrow of anti-mu treated mice retain their functional integrity, as evidenced by their ability to give rise to sIgM+, LPS-responsive lymphocytes in culture. We also show that cyclophosphamide treatment destroys pre-B cells and that recovery of pre-B cells in bone marrow precedes the regeneration of sIgM+ B lymphocytes. Generation of B lymphocytes in adult mice apparently occurs exclusively in the bone marrow because induction of extramedullary hemopoiesis in spleen was not accompanied by the appearance of pre-B cells in that organ.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96180

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets.

Authors:  G F Tidmarsh; S Heimfeld; C A Whitlock; I L Weissman; C E Müller-Sieburg
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

2.  Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages.

Authors:  J A Edwards; D B Jones; P R Evans; J L Smith
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

3.  Cycling of peripheral blood and marrow lymphocytes in cyclic neutropenia.

Authors:  D Engelhard; K S Landreth; N Kapoor; P W Kincade; L E De Bault; A Theodore; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Increase and inhibition of pre-B cell proliferation in culture, by T cells.

Authors:  P Paolucci; L Layward; A R Hayward; N T Rapson; J F Soothill
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

Review 5.  Pre-B cells; normal and abnormal development.

Authors:  M D Cooper
Journal:  J Clin Immunol       Date:  1981-04       Impact factor: 8.317

6.  Mice completely suppressed for the expression of immunoglobulin kappa light chain.

Authors:  S Weiss; K Lehmann; W C Raschke; M Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

7.  Development of pre-B and B lymphocytes in the human fetus.

Authors:  G E Asma; R Langlois van den Bergh; J M Vossen
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

8.  Growth of pre-B cells in cultures of bone marrow from children with acute lymphoblastic leukaemia and other diseases.

Authors:  P Paolucci; N T Rapson; L Layward; A R Hayward
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

9.  Enhancement of sheep erythrocyte (SRBC)-induced pleurisy in non-sensitized mice by cyclophosphamide: demonstration of natural cell-mediated immune reactivity to SRBC.

Authors:  S Yamamoto; Y Higuchi; H Teshima
Journal:  Immunology       Date:  1982-09       Impact factor: 7.397

10.  Pre-B cell suppression by thymoma patient lymphocytes.

Authors:  A R Hayward; P Paolucci; A D Webster; P Kohler
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.